News
//75Results
Corporate News
Merz Group Expands Management Board: Dr. Almuth Steinkühler Appointed New Chief Financial Officer (CFO)
Frankfurt am Main /
Frankfurt am Main, October 28 – The Merz Group, an international, diversified, family-owned healthcare company, is positioning itself for the future by expanding its Executive Board: Effective November 1, Dr.…
Read moreCorporate
Generational transition of Shareholder Leadership in the family owned Merz Group
Frankfurt am Main /
Carefully planned leadership transition ensures continuity and renewal. Frankfurt am Main / 06.01.2025 / Merz has been under the ownership of its founding family since its establishment in 1908. Merz…
Read moreCorporate
Merz enters Asset Purchase Agreement with a US-based biotech company
Frankfurt am Main /
Second investment in a NASDAQ company in just over ten years. Frankfurt am Main, Germany / April 1, 2024 / Merz Therapeutics, a business of Frankfurt-based Merz Group, has entered…
Read moreCorporate
New CEO for Merz Therapeutics: Stefan König
Frankfurt am Main /
Mexico City, London, and now Frankfurt am Main, Germany: Experienced Pharma manager appointed to lead Merz Therapeutics As of immediately, Stefan König will be responsible for Merz Therapeutics GmbH as…
Read moreCorporate News
New CEO for Merz Consumer Care: Xenia Barth
Frankfurt am Main /
As an experienced manager for consumer beauty care marketing and sales, Xenia Barth is taking over the management of Merz Consumer Care. From now on, Xenia Barth will be responsible…
Read moreNeurotoxin
XEOMIN® (incobotulinumtoxinA) Receives European Approval for the Treatment of Chronic Sialorrhea in Children
Frankfurt, Germany /
First and only botulinum neurotoxin approved for this indication in Europe Today, Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, has been…
Read moreCorporate
Merz and Israeli start-up Vensica launch partnership for needleless treatment of overactive bladder
Frankfurt, Germany /
Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and the Israeli start-up Vensica Therapeutics Ltd., a urology company, announced today that they…
Read moreNeurotoxin
Teijin Receives Additional Approval in Japan for Merz’s Xeomin® Botulinum Toxin Type A
Frankfurt, Germany /
Merz Therapeutics, a business of the Merz Group and a leader in the field of neurotoxins, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly…
Read moreCorporate
Merz Healthcare Breaks Even Despite COVID-19 Pandemic in Fiscal Year 2019/20
Frankfurt, Germany /
Net consolidated operating profit of the Frankfurt family business amounts to EUR 38.8 million Partnership with Gwyneth Paltrow and investment in start-up Brooklyn Soap Company Investments in the new organizational structure pay…
Read moreNeurotoxin
Teijin Receives Marketing Approval for Merz’s Xeomin®
Frankfurt am Main, Germany /
Merz Pharmaceuticals GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, jointly…
Read more